Makoto Fukuoka
Suita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: February 20, 2024
Genome-wide loss-of-function genetic screen identifies INSIG2 as the vulnerability of hepatitis B virus-integrated hepatoma cells.
Journal: Cancer science
Published: October 09, 2023
Pentraxin 3 is an adipose tissue-related serum marker for pancreatic cancer cachexia predicting subsequent muscle mass and visceral fat loss.
Journal: Cancer science
Published: May 25, 2022
Inhibition of nonhomologous end joining-mediated DNA repair enhances anti-HBV CRISPR therapy.
Journal: Hepatology communications
Published: February 16, 2022
Capsid Allosteric Modulators Enhance the Innate Immune Response in Hepatitis B Virus-Infected Hepatocytes During Interferon Administration.
Journal: Hepatology communications
Published: January 14, 2021
SIRT1 enhances hepatitis virus B transcription independent of hepatic autophagy.
Journal: Biochemical and biophysical research communications
Published: April 08, 2020
Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer.
Journal: British journal of cancer
Published: March 16, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026